Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Smoking Impairs Cognition and Shrinks Brain Volume in MS

Publish date:: November 1, 2019

Key clinical point: Patients with MS who quit smoking tobacco may experience improved cognitive function.

Major finding: Former smokers with MS scored an average of 3.6 points lower on the Processing Speed Test than never smokers, and current smokers scored 5.9 points lower.

Study details: This cross-sectional study included 997 patients with MS who had cognitive function test scores and brain MRIs.

Disclosures: The study presenter reported having no relevant financial interests.

Citation:

Alshehri E et al. ECTRIMS 2019. Abstract P461.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Multiple Sclerosis

Long-term safety and efficacy of teriflunomide for relapsing MS,

Newer DMTs are more effective than injectable DMTs in pediatric MS,

Neutrophil granulocyte markers may distinguish between demyelinating diseases,

Bacteria may be associated with risk of MS relapse,

Women with MS may have increased subclinical disease activity during pregnancy,